Bupivacaine Hcl 0.25% Inj
Bupivacaine Hcl 0.25% Inj is a pharmaceutical drug with 9 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
2
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Sciatic Nerve Block With ALX006 in Subjects Undergoing Bunionectomy
Multifidus Cervicis Plane Block Vs. Sham Block For Posterior Cervical Spine Fusion Surgery
Measuring Opioid Use After Rotator Cuff Repair: Comparing the Effects of Standard vs. Extended-release Nerve Blocks
Erector Spinae Plane Block Versus Perioperative Intravenous Lidocaine for Thoracotomy
Exparel vs. Bupivacaine Hydrochloride vs. Placebo for Hernia Repair
Clinical Trials (9)
Sciatic Nerve Block With ALX006 in Subjects Undergoing Bunionectomy
Multifidus Cervicis Plane Block Vs. Sham Block For Posterior Cervical Spine Fusion Surgery
Measuring Opioid Use After Rotator Cuff Repair: Comparing the Effects of Standard vs. Extended-release Nerve Blocks
Erector Spinae Plane Block Versus Perioperative Intravenous Lidocaine for Thoracotomy
Exparel vs. Bupivacaine Hydrochloride vs. Placebo for Hernia Repair
Subarachnoid Block With Ultrasound-Guided Transversalis Fascia Plane Block for Cesarean Section
Use of Exparel for Postoperative Analgesia Following Bariatric Surgery
Erector Spinae Plane Block Versus Serratus Plane Block for Breast Surgery
Comparison of Erector Spinae Plane Block With Thoracic Paravertebral Block for Video Assisted Thoracoscopic Surgery
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9